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Introduction
Metastatic involvement in vertebral bone occurs in up to 1/3 of cancer patients 1 and can manifest as bone-resorbing (osteolytic), bone forming (osteoblastic) or a mixture of the two. Vertebral metastasis has been linked with diminished mechanical integrity of the spine with bone metastases leading to a high incidence (~66%) of skeletal related events (SREs), which can significantly impact quality of life and physical function 2 .
Previous work has focused on structural, mechanical and mineral density changes in metastatically involved bone with respect to the risk and pattern of fracture .However, these detected modifications in total bone structure or mass may not fully account for observed SREs due to modified mechanical behaviour. The intrinsic material characteristics of bone has been shown to be impacted by pathological conditions such as type-I diabetes 5 and should be accounted for in metastatic involvement.
Bone is a complex two-phase composite material whose material properties are dependent on both its organic (collagen) and mineral (hydroxyapatite) components and their combined ultrastructure. In its organic phase, the rectilinear array of collagen type-I fibrils provides bone with enhanced ductility increasing the tissue's toughness 6 . This observed fibrillar structure, into which the helical collagen-I molecules aggregate, is maintained and stabilized in part by the formation of covalent cross-links between these molecules. These cross-links can be formed through enzymatic pathways connecting the non-helical telopeptides of adjacent collagen molecules 7 to form immature divalent cross-links or mature trivalent cross-links or through nonenzymatic pathways connecting the helical peptides 8 . A variety of enzymatic and non-enzymatic cross-links exist within bone but studies tend to focus on the analysis of the trivalent mature enzymatic pyridinium cross-links: pyridinoline (pyr) and deoxy-pyridinoline (dpyr); and the nonenzymatic crosslink: pentosidine (pen) 5, 9, 10 . This focus is due to the natural fluorescence of these cross-links making them easily identifiable markers in high performance liquid chromatography (HPLC) 5, 11 . Decreases in pyridinium cross-links has been associated with a reduction in bending strength and the elastic modulus of bone 12 . Modifications in the ratio between immature crosslinks and mature pyridinium cross-link levels within bone have been associated with changes in observed bone strength or toughness 9 . Increase in non-enzymatic crosslinks have been shown to negatively impact bone ductility, toughness and post-yield properties [13] [14] [15] . While no data exists for metastatically involved bone, pathologic bone secondary to diabetes and osteoporosis has demonstrated increases in pen levels suggesting pen level's potential as a biomarker to pathologic bone tissue. 5, 9, 16 . Note, these studies utilized bone samples for direct and absolute measurement of cross-link concentration. While this allows for assessment of cross-link changes due to both bone turnover and pathologically formed bone, pen levels can be inferred by concentration detected in urine or serum due to turnover
Formation of these cross-links could be impacted by numerous factors. An imbalance between produced reactive oxygen species (ROS) and the local system's ability to counteract with sufficient anti-oxidising mechanisms and repair potential damage (known as oxidative stress)
could provide an environment conducive to oxidative reactions associated with advanced glycation endproduct (AGE) formation 9, 17 . Additionally, hydroxylation of residues such as lysine in the collagen molecule are critical in dictating the pathways of enzymatic cross-link formation 18 . . Carbonate within the apatite structure has also been associated with a modification in crystal structure with observed decreases in crystal dimensions or increased lattice strain
23
. Some work has started to study the impact of metastasis on the mineral crystal structure through Raman spectroscopy showing patterns of decreased crystallinity, crystal size and increased carbonation
24
. This impact could also be cyclic in nature as factors such as crystallinity and crystal size have been shown to impact metastatic cell behaviour 25, 26 . Raman spectroscopy can also be utilized to assess the mineral/collagen ratio within bone tissue indicative of tissue mineral density instead of observing total bone mass.
To understand the material behaviour of metastatically involved bone requires evaluation of changes which occur in both organic and mineral phases. As such, this study aims to evaluate collagen cross-linkage and mineral crystal structure in osteolytic and mixed metastatically involved vertebral bone using well established in vivo rat models 27, 28 . It is hypothesized that due to the associated increase of reactive oxygen species (ROS) production with cancer cells 
Material/Methods
Animal model and metastatic inoculation: Well established rat models for studying spinal metastases were utilized 27, 28, 34 . These models use systemic inoculation of tumour cells to simulate the physiologic development of vertebral metastases. The animal use protocol was approved by the Ontario Cancer Institute prior to performing the study. Randomly assigned 5-6 week old athymic female rnu/rnu rats were inoculated with human HeLa cervical cancer cells (previously misidentified as MT-1 cells) to create osteolytic metastases or canine Ace-1 prostate cancer cells to produce mixed (osteolytic/osteoblastic) metastases (N=17 per group). An additional 12 rats were used as healthy controls. The HeLa and Ace-1 cell lines were cultured in RPMI and DMEM/F-12 media respectively at 37°C with 5% CO2 and stably transfected with the luciferase gene to enable bioluminescent image monitoring of tumor growth within the rat via subcutaneous injection of luciferin. Cultured cell viability was determined utilizing a trypan blue exclusion. Rats were anesthetised using nose-cone inhalation of a 2% halothane/air mixture.
Intracardiac injections containing ~1.5×10 6 cells (in 0.2mL of media) were injected into the left heart ventricle. After 14 and 21 days, bioluminescence imaging (Xenogen) was performed for detection and semi-qualitative assessment of the degree of metastatic growth within the rat, and particularly in the spine. The rats were euthanized 21 days after initial inoculation via CO2 asphyxiation, their vertebrae harvested and wrapped in saline dampened gauze and stored in -20˚C freezer until testing. In cases of premature rat death the vertebrae were removed immediately and noted accordingly.
High Performance Liquid Chromatography: HPLC was performed to quantify crosslinks using a previously published protocol 11, 35, 36 . Briefly, soft tissue was removed from extracted T12-T13 vertebrae via papain digestion. Samples were defatted and then hydrolyzed in 11 M HCl at 110°C for 24 h. Samples were diluted and added to a sample buffer containing 10% acetonitrile, 1% HFBA and water plus an internal standard (pyridoxine). Pyridinoline, deoxy-pyridinoline and pentosidine were quantified against standards of pentosidine (PolyPeptide Group, Strasbourg, France) and pyridinoline (Qiagen, Hilden, Germany). Agilent Zorbax Eclipse XDB- The degree of proline hydroxylation was also determined by hydroxyproline/proline ratio.
Raman Spectroscopy: Extracted T8 vertebrae were cut in the sagittal plane with a diamond blade (Buehler, Illinois, USA) then polished with grit papers (600, 1200, 2400, 4000 and diamond paste 3um and 1um). The bone specimens were thawed in a 4°C refrigerator 24 hours prior to Raman spectra acquisition. Acquisition was done with an inVia Confocal Raman Microscope (Renishaw, Gloucestershire, UK) which includes a Renishaw spectrometer coupled into a DMI6000 epifluorescence microscope (Leica, Wetzar, Germany). A 785 nm laser light was used to focus on the vertebral body through a Leica HC PLAN APO 20x/0.70NA (laser power 3 mW, spot size 4um in the y direction and 0.5um in the x direction). The bone sample was kept wet with PBS, each sample had 3-5 locations tested and 4-6 spectra were acquired from each location From these intensities, a number of ratios were calculated for analysis. The mineral/matrix ratio (phosphate ν1/proline+hydroxyproline) and carbonate/matrix ratio (carbonate/ proline+hydroxyproline) illuminate the degree of mineralization of the bone tissue.
Proline+hydroxyproline were chosen as the matrix factors to utilize in the mineral/matrix and carbonate/matrix ratios due to those factors having a distinct tie to collagen-I
37
. Mineral crystallinity (1/FWHM of phosphate ν1 peak), carbonate/phosphate ν1 ratio (indicative of mineral carbonation), hydroxyproline/proline ratio (indicative of proline hydroxylation), and the collagen quality parameter (mature/immature enzymatic cross-link ratio) were also calculated and compared between sample groups.
Statistical data analysis:
For each data set, the normality of the data was evaluated utilizing the Shapiro-Wilk test. If the normality assumption held, then a test for the homogeneity of variance between groups via Levene's test was performed. In data sets without equal variance, Welsh followed by Tamhane post hoc tests for multiple comparisons were performed to test for differences between sample groups. When equal variance and normality could be assumed, analysis of variance followed by the Tukey post hoc test for multiple comparisons between samples groups were used. In cases where the normality assumption could not be held, the Kruskal-Wallis H test followed by the Dunn-Bonferroni post-hoc approach for multiple comparisons between sample groups were used. All data are presented as mean±standard deviation, with a significance level of p<0.05 (SPSS v23, SPSS, Chicago, IL, USA). 
Results

Metastatic
Cross-link and Proline Hydroxylation Quantification via HPLC:
The non-enzymatic cross-link pentosidine showed a large statistically significant increase (2.4x, p<0.05) in observed pen levels in osteolytic vertebrae compared to healthy controls (Figure 3a) . Although total pyridinium cross-links content showed no significant difference between healthy and metastatic involved bone, a trend (p = 0.087) was observed between osteolytic and mixed bone samples (Figure 3b ).
Deoxy-pyridinoline levels were significantly lower (p<0.05) in the osteolytic compared to the mixed vertebrae (Figure 3c ). There were no significant differences in pyridinoline levels between the 3 groups (Figure 3d ). There was a significant increase in hydroxyproline formation (~16%, p<0.05) in osteolytic bone compared to healthy controls (Figure 4a ) with no statistically significant changes in proline concentration (Figure 4b ). Osteolytic bone samples demonstrated a trend toward an increase (~6%) in the hydroxyproline/proline ratio (Figure 4c ) compared to mixed bone and healthy controls (p = 0.053, p = 0.077, respectively).
Modifications in Mineralization, Collagen Quality and Proline Hydroxylation Ratios assessed
via Raman: Modifications in both crystallinity and crystal structure were found due to metastatic involvement. The 1/FWHM value of ν1Phosphate peak showed a small but statistically significant decrease (~3%) in the osteolytic group compared to both the mixed model and healthy controls, indicative of decreased crystallinity (Figure 5a ). The carbonate/phosphate ratio in the osteolytic samples was elevated (~6%) compared to the other groups, implying increased carbonate ion substitution in the crystal lattice (Figure 5b ).
The mineral/matrix ratio showed a statistically significant decrease in the presence of the phosphate component of hydroxyapatite relative to the proline/hydroxyproline residues specific to collagen-I for both osteolytic (~ 15%) and mixed groups (~11%) versus healthy controls (Figure 5c ). There was also a decrease in the carbonate/matrix ratio in bone with metastatic involvement (Figure 5d ).
The collagen quality parameter, thought to be indicative of the level of the ratio between mature and immature cross-links, was moderately reduced (5%) in osteolytic samples compared to both mixed and healthy controls (Figure 5e ). Additionally, there were observed differences in the hydroxyproline/proline ratio between all three samples groups with osteolytic samples exhibiting the highest ratio (~ 10% increase) (Figure 5f ).
Discussion
Both the organic and mineral phases of metastatically involved vertebrae demonstrated changes as compared to healthy controls, suggesting that tumour induced changes impact the remaining bone at a material level. The most striking differences were seen in pentosidine (pen) levels. Pen is an AGE crosslink between lysine and arginine found in the helical domains of adjacent collagen molecules. Pathological conditions such as Type 1 and Type 2 diabetes considered to negatively impact bone quality have been shown to modify the quantity of collagen cross-link formed within bone tissue 5, 9 . In each case, pen levels were shown to increase. This, combined with increased pen levels being associated with diminished bone mechanical properties 13, 14 , implies an importance of pen as a potential biomarker for poor bone quality and a risk factor for fracture. In our study, osteolytic metastatic involvement within the vertebrae (HeLa) was shown to greatly increase the formation of pen in the bone. In general, an increase in ROS species concentration associated with the presence of cancer cells However, Ace-1 metastatic involvement did not impact pen levels in a statistically significant manner. This contrast to the HeLa involvement could be due to variability in tumour burden among samples. An increase in pen has been linked to diminished bone quality and may act as a marker for oxidative stress and AGE production which can impact bone remodelling 13, 14 .
Amplified concentrations of ROS can damage the extracellular matrix (collagen) and impact cellular metabolic reactions (osteoblasts and osteoclasts remediated bone remodelling)
38
.
Collagen degradation, both in terms of fragmentation and susceptibility to enzymatic degradation, has been shown to be facilitated by ROS presence 39, 40 . All these factors combined with other AGE presence may have an impact on bone's mechanical behaviour. . Note, post-hoc power analysis showed that the comparison of dpyr differences was underpowered (power=0.48). This may have impacted the ability to detect a statistically significant difference between osteolytic and healthy bone (p=0.114). This general decrease in pyridinium cross-link formation is likely due to competitive utilization of lys and hlys residues in AGE formation creating a deficiency in the formation of enzymatic cross-links. The emphasis on dpyr decrease compared to pyr might be due to the potential increase in the hydroxylation of lysine, limiting the available of helical lys which is required in dpyr formation but not for pyr formation. Unfortunately, we did not measure lysine hydroxylation in this study.
Hydroxylation of proline in collagen is mediated by the enzyme prolyl hydroxylase. The presence of hydroxyproline in collagen is critical for the stability of the collagen triple helix via hydrogen bonding interactions. Additionally, the polar interactions between protruding hydroxyl groups of collagen molecules within collagen fibrils could impact both the chemical and observed physiological properties of the fibril. For example, it has been shown that hydroxylation is favourable for HA nucleation and growth
44
. The expression of prolyl hydroxylase has been linked to cancer metastases in primary tumours often associated with bone metastasis, likely to facilitate increased extracellular matrix production to providing structure for tumour cell adhesion, growth and taxis 30, 45 . Additionally, ROS species associated with metastatic involvement could potentially lead to non-enzymatic hydroxylation of amino residues
41
. Therefore metastases could facilitate an increase in non-enzymatic hydroxylation and the prolyl hydroxylase levels in the bone micro-environment promoting increased hydroxyproline expression and the observed increase in the hydroxyproline/proline ratio in metastatic bone groups compared to healthy controls. Note that in this study, the modifications in hydroxyproline/proline ratio observed among sample groups was different between HPLC and
Raman. HPLC provides absolute values on the quantity of proline and hydroxyproline residue within all bone in the vertebrae whereas Raman analysis does not provide absolute values (just the ratio), is focal in nature, and locations of analysis were chosen by their likely proximity to tumour. This difference in data collection methodology could account for Raman's perceived increased sensitivity in detecting differences in the hydroproline/proline ratio in metastatically involved bone and suggests that tumour impact on bone collagen and bone is proximal in nature.
Note, although hydroxyproline levels may be modified with metastatic involvement, its expression as the gold standard in measuring collagen content was utilized.
Proline and hydroxyproline were chosen as the matrix factors to utilize in the mineral/matrix and carbonate/matrix ratios in Raman due to those factors having a distinct tie to collagen-I
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. The observed decrease in the mineral/matrix ratio for both the osteolytic and mixed bone samples agrees with decreases in tissue mineral density associated with metastatic involvement observed via other modalities (i.e. µCT scanning + segmentation , pycnometry + mass measurements)
4, 27,
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Metastatic involvement has been previously shown to both influence and be influenced by hydroxyapatite (HA) crystallinty and crystal size 25, 26 . Our results revealed a decrease in crystallinity in osteolytic samples compared to healthy controls (p<0.05) with a similar pattern 
